Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trialAna Oaknin, Juan Cueva, Laurence Gladieff et al.|The Lancet|2023Cited by 225
Systemic mastocytosis and bone involvement in a cohort of 75 patientsStéphane Barète, C. Françès, Frédéric Féger et al.|Annals of the Rheumatic Diseases|2010Cited by 163